Answers are grounded in this paper and cite their sources.
Cancer, a formidable adversary, continues to challenge the boundaries of medical science.As we strive to enhance our understanding and diagnostic capabilities, proteomics emerges as a pivotal player in the early detection of cancer.This dynamic field, focusing on the study of proteins and their interactions within biological systems, holds immense promise for revolutionising our approach to cancer diagnosis.[1] Early detection is a game-changer in the battle against cancer, significantly improving patient outcomes and survival rates.Proteomics, through its ability to analyse the intricate protein profiles in biological samples, provides a powerful tool for identifying biomarkers indicative of early-stage cancer.By scrutinising subtle variations in protein expression and post-translational modifications, proteomic technologies offer a comprehensive snapshot of the molecular landscape associated with the onset of malignancy.
No takes yet. Share an insight, caveat, or question.
Abhishek Pathak (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: